Dr. Pavel Strnad is a full professor and leading physician at the University Hospital Aachen, Germany. In 2016, he was named one of the Rising Stars of the United European Gastroenterology. He is heading a European initiative for the study of alpha1-antitrypsin deficiency-associated liver disease. His clinical interests include (but are not limited to) rare and metabolic liver disease as well as liver transplantation. His research focuses on structural proteins and complex datasets. Dr. Pavel Strnad's clinical research consists of 161 co-authored peer-reviewed articles and participating in leading positions in multiple clinical trials in the past 15 years. He is currently a global PI on three clinical trials.